Thomas Dörner works as a Professor of rheumatology and clinical immunology at Charité University Hospitals Berlin, Germany, and as a Group Leader of the B cell memory group at the German Research Centre of Rheumatology Berlin. During his postdoc, he worked at the University of Texas, Southwestern Medical Center at Dallas, delineating molecular aspects of the B cell receptor gene usage. He has served as a Member of editorial boards of leading journals in rheumatology, including Arthritis and Rheumatism, Arthritis Research and Therapy, and Rheumatology Reviews. Since 1998, Professor Dörner has participated in various clinical trials of rheumatic diseases, including SLE, Sjögren’s syndrome, rheumatoid arthritis, and seronegative spondyloarthropathies. His scientific interests include the characterization of disturbances of humoral autoimmunity and abnormalities of B cell subsets in the blood versus tissue (lupus, neonatal lupus syndromes, and Sjögren’s syndrome), exploring innovative therapeutic approaches with a main focus on B cell directed therapy, as well as improving diagnostic tools in autoimmune diseases. In addition, his group is interested in the complex activation of the immune and coagulation system, including a specialized clinic for patients with rheumatic and clotting disorders. He has been awarded a number of international and national awards, such as the Senior Scholar Award of the American Society of Rheumatology, the H Schultze Award of the German League against Rheumatism, and the Schoen Award of the German Society of Rheumatology.
Biography Updated on 30 September 2014